Insulin companies, PBMs pass the blame as they face bipartisan ire on pricing ...Middle East

The Hill - News
Insulin companies, PBMs pass the blame as they face bipartisan ire on pricing
Major stakeholders in the pharmaceutical industry on Wednesday testified in front of a key Senate panel to address questions over the affordability of insulin, with the assembled witnesses, as expected, passing the blame amongst each other. Leaders from top insulin manufacturers Eli Lilly, Novo Nordisk and Sanofi joined with executives from top pharmacy benefit management (PBM) companies CVS Health, Express Scripts and OptumRx to face the grilling from lawmakers on the Senate Committee on Health, Education, Labor and Pensions (HELP). In their opening statements, drug manufacturing leaders cited numerous causes of insulin’s sky-high price that exist outside their companies.  Eli L

Hence then, the article about insulin companies pbms pass the blame as they face bipartisan ire on pricing was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Insulin companies, PBMs pass the blame as they face bipartisan ire on pricing )

Apple Storegoogle play

Last updated :

Also on site :